​The research group has succefully secured a fund of 70,000 USD form the Deanship of Scientific Research at JU, for a new project to develope peptide nucleic acid for breast cancer therapy.

Through this project, we aim to inhibit cancer-related pathways, reduce tumor growth, and enhance the efficacy, specificity, and safety of gene therapy for cancer treatment.​